INTERLEUKIN-2-FC FUSION PROTEINS AND METHODS OF USE

Provided are serum half-life extended-IL-2 variant (IL-2v) heterodimers having reduced binding to the IL2Rα (CD25) subunit. In particular, Fc-IL-2v heterodimers are provided and methods for making and using, e.g. for enhancing an immune response, e.g. in the prevention and treatment of viral infecti...

Full description

Saved in:
Bibliographic Details
Main Authors PAPALIA, Giuseppe, BACA, Manuel, GILMORE, Sarah A, MUKHERJEE, Prasenjit K, TAM, Danny W, JAVANBAKHT, Hassan, HUNG, Magdeleine S, KHAN, Shahzada, THOMAS, Majlinda K, KANWAR, Manu, NAGEL, Mark R
Format Patent
LanguageEnglish
French
Published 28.04.2022
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Provided are serum half-life extended-IL-2 variant (IL-2v) heterodimers having reduced binding to the IL2Rα (CD25) subunit. In particular, Fc-IL-2v heterodimers are provided and methods for making and using, e.g. for enhancing an immune response, e.g. in the prevention and treatment of viral infections and cancer. L'invention concerne des hétérodimères de variant d'IL-2 (IL-2v) à demi-vie sérique prolongée ayant une liaison réduite à la sous-unité IL2Rα (CD25). En particulier, l'invention concerne des hétérodimères de Fc-IL -2v et des méthodes de fabrication et d'utilisation, par exemple d'amélioration d'une réponse immunitaire, par exemple dans la prévention et le traitement d'infections virales et du cancer.
AbstractList Provided are serum half-life extended-IL-2 variant (IL-2v) heterodimers having reduced binding to the IL2Rα (CD25) subunit. In particular, Fc-IL-2v heterodimers are provided and methods for making and using, e.g. for enhancing an immune response, e.g. in the prevention and treatment of viral infections and cancer. L'invention concerne des hétérodimères de variant d'IL-2 (IL-2v) à demi-vie sérique prolongée ayant une liaison réduite à la sous-unité IL2Rα (CD25). En particulier, l'invention concerne des hétérodimères de Fc-IL -2v et des méthodes de fabrication et d'utilisation, par exemple d'amélioration d'une réponse immunitaire, par exemple dans la prévention et le traitement d'infections virales et du cancer.
Author BACA, Manuel
KHAN, Shahzada
MUKHERJEE, Prasenjit K
NAGEL, Mark R
GILMORE, Sarah A
HUNG, Magdeleine S
TAM, Danny W
THOMAS, Majlinda K
KANWAR, Manu
JAVANBAKHT, Hassan
PAPALIA, Giuseppe
Author_xml – fullname: PAPALIA, Giuseppe
– fullname: BACA, Manuel
– fullname: GILMORE, Sarah A
– fullname: MUKHERJEE, Prasenjit K
– fullname: TAM, Danny W
– fullname: JAVANBAKHT, Hassan
– fullname: HUNG, Magdeleine S
– fullname: KHAN, Shahzada
– fullname: THOMAS, Majlinda K
– fullname: KANWAR, Manu
– fullname: NAGEL, Mark R
BookMark eNrjYmDJy89L5WQw9vQLcQ3ycQ319vTTNdJ1c1ZwCw329PdTCAjyD3H19AtWcPRzUfB1DfHwdwlW8HdTCA125WFgTUvMKU7lhdLcDMpuriHOHrqpBfnxqcUFicmpeakl8eH-RgZGRgYW5oYmlo5GxsSpAgAvkymg
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate PROTÉINES DE FUSION D'INTERLEUKINE-2-FC ET MÉTHODES D'UTILISATION
ExternalDocumentID WO2022087149A2
GroupedDBID EVB
ID FETCH-epo_espacenet_WO2022087149A23
IEDL.DBID EVB
IngestDate Fri Sep 27 05:30:58 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
French
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_WO2022087149A23
Notes Application Number: WO2021US55877
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220428&DB=EPODOC&CC=WO&NR=2022087149A2
ParticipantIDs epo_espacenet_WO2022087149A2
PublicationCentury 2000
PublicationDate 20220428
PublicationDateYYYYMMDD 2022-04-28
PublicationDate_xml – month: 04
  year: 2022
  text: 20220428
  day: 28
PublicationDecade 2020
PublicationYear 2022
RelatedCompanies GILEAD SCIENCES, INC
RelatedCompanies_xml – name: GILEAD SCIENCES, INC
Score 3.393191
Snippet Provided are serum half-life extended-IL-2 variant (IL-2v) heterodimers having reduced binding to the IL2Rα (CD25) subunit. In particular, Fc-IL-2v...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
Title INTERLEUKIN-2-FC FUSION PROTEINS AND METHODS OF USE
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220428&DB=EPODOC&locale=&CC=WO&NR=2022087149A2
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LS8NAEB5KFfWmVfFRZUHJbbFNtmn3UKRNNgQxSWkT7a1k84CCpMVG_PvOxlR76m0fsC_4Zuab3ZkFeEz0TpLpPKac5x3KYjmgMuMZRcvANNNc9tJEuQY833Qj9jLvzRvwsY2FqfKEflfJERFRCeK9rOT1-t-JZVdvKzdPcolNq2cnHNpazY51XVEAzR4PxSSwA0uzLORtmj_97UNywPgIBfYBGtJ9hQfxNlZxKetdpeKcwuEExyvKM2hkRQuOre3fay048uorbyzW6Nucg1Hlr30VEVJuqlPHIk6kZCGZTINQIA0nI98mngjdwJ6RwCHRTFzAgyNCy6U4--Jvs4v3YHepxiU0i1WRXQHpszxnkqPFYcYs70ieopAzEK7dbm6mLL6G9r6RbvZ338KJqqp7En3Qhmb5-ZXdobot5X11Sj_P_n3W
link.rule.ids 230,309,783,888,25576,76876
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dT8IwEL8QNOKbosYP1CaavTXCKIM-EANbl6lsI7Apb2TdR2JiBpEZ_32vE5Qn3ppe0q_kd73fXe8KcB_rzTjVeUQ5z5qURbJHZcpTipaBYSSZ7CSxcg24nuGE7HnWmVXgY5MLU9YJ_S6LIyKiYsR7Uerr5b8TyyrfVq4e5Dt2LR7toG9pa3as64oCaNawL8a-5ZuaaSJv07zJrwzJAeMDVNh7aGR3FR7E61DlpSy3LxX7CPbHOF5eHEMlzetQMzd_r9XhwF2HvLG5Rt_qBNpl_dqRCJFyU53aJrFDpQvJeOIHAmk4GXgWcUXg-NaU-DYJp-IU7mwRmA7F2ed_m52_-dtLbZ9BNV_k6TmQLssyJjlaHEbEsqbkCSq5NsK11cqMhEUX0Ng10uVu8S3UnMAdzUdP3ssVHCqRipnovQZUi8-v9Bqv3kLelCf2A-IUgMk
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=INTERLEUKIN-2-FC+FUSION+PROTEINS+AND+METHODS+OF+USE&rft.inventor=PAPALIA%2C+Giuseppe&rft.inventor=BACA%2C+Manuel&rft.inventor=GILMORE%2C+Sarah+A&rft.inventor=MUKHERJEE%2C+Prasenjit+K&rft.inventor=TAM%2C+Danny+W&rft.inventor=JAVANBAKHT%2C+Hassan&rft.inventor=HUNG%2C+Magdeleine+S&rft.inventor=KHAN%2C+Shahzada&rft.inventor=THOMAS%2C+Majlinda+K&rft.inventor=KANWAR%2C+Manu&rft.inventor=NAGEL%2C+Mark+R&rft.date=2022-04-28&rft.externalDBID=A2&rft.externalDocID=WO2022087149A2